Latest news
Clearmind Medicine (Nasdaq: CMND) wins DSMB nod to advance AUD trial - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:03 GMTClearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:21:58 GMTCMND-100 Set to Enter Human Testing for Moderate-to-Severe Alcohol Use Disorder - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTClearmind advances CMND-100 alcohol use disorder trial into patient testing after Phase I safety readout - BitgetBitget · Thu, 06 Aug 2026 05:26:57 GMTClearmind Medicine to acquire 51% stake in EV charging firm - Investing.comInvesting.com · Mon, 03 Aug 2026 12:38:06 GMTClearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:02:00 GMTClearmind Medicine to acquire 51% stake in EV w... - PluangPluang · Mon, 03 Aug 2026 07:00:00 GMTClearmind's CMND-100 trial reaches 160 mg with no serious adverse events - Stock TitanStock Titan · Thu, 30 Jul 2026 12:30:00 GMT